Novavax (NVAX) PT Lowered to $190 at Jefferies Ahead of Earnings
Tweet Send to a Friend
Jefferies analyst Roger Song lowered the price target on Novavax (NASDAQ: NVAX) to $190.00 (from $198.00) after hosting a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
